EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Fertility treatment using assisted reproductive technology during immune checkpoint inhibition: report of two cases

Keri Tomechko, Tali Azenkot iD, Deirdre A Conway, Sandip Pravin Patel, H Irene Su

The Oncologist · 08.07.2026 · 31 (8)

DOI: 10.1093/oncolo/oyag273 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Oncologist, online erschienen am 15.07.2026. Verfasst von Keri Tomechko und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California San Diego, San Diego, CA, 92093, United States. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Reproductive Techniques, Assisted, Lung Neoplasms, Fertility Preservation. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited data to guide fertility counseling for patients on prolonged immune checkpoint inhibition. Concerns include potential teratogenicity, decline in ovarian reserve and spermatogenesis, and endocrine immune-related adverse events such as hypophysitis. As indications for checkpoint inhibition expand, an increasing number of reproductive-aged patients face fertility-related decisions around active therapy. We present two patient cases, one male and one female, who used assisted reproductive technology to support family building during maintenance immune checkpoint inhibitor therapy. A female lung cancer survivor underwent in vitro fertilization and froze six euploid blastocyst embryos for gestational surrogacy. A male gastroesophageal junction cancer survivor and his female partner underwent in vitro fertilization followed by a medicated intrauterine insemination cycle to conceive healthy fraternal twins. While prospective data are needed, this case series supports the feasibility of fertility treatment during checkpoint inhibitor therapy and highlights remaining clinical questions regarding this important aspect of cancer survivorship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsReproductive Techniques, AssistedLung NeoplasmsFertility PreservationHumansFemaleMaleAdultPregnancy

Stichwörter der Autor:innen

immune checkpoint inhibitorimmune-related adverse eventoncofertilitysolid tumorsurvivorship

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • School of Medicine, University of California San Diego, San Diego, CA, 92093, United States.
  • Moores Cancer Center, University of California, San Diego, CA, 92037, United States.
  • Utah Fertility Center, Utah, United States.
  • Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, CA, United States.

ORCID-Profile: Tali Azenkot

Zitieren

APA

Tomechko, K., Azenkot, T., Conway, D. A., Patel, S. P., & Irene Su, H. (2026). Fertility treatment using assisted reproductive technology during immune checkpoint inhibition: report of two cases. The Oncologist, 31(8). https://doi.org/10.1093/oncolo/oyag273

Vancouver

Tomechko K, Azenkot T, Conway DA, Patel SP, Irene Su H. Fertility treatment using assisted reproductive technology during immune checkpoint inhibition: report of two cases. The Oncologist. 2026;31(8). doi:10.1093/oncolo/oyag273

BibTeX
@article{Tomechko2026,
  author = {Tomechko, Keri and Azenkot, Tali and Conway, Deirdre A and Patel, Sandip Pravin and Irene Su, H},
  title = {Fertility treatment using assisted reproductive technology during immune checkpoint inhibition: report of two cases},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {8},
  doi = {10.1093/oncolo/oyag273}
}
Kostenlos starten →